Publication | Closed Access

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

OncologyRandomised Phase 3Bevacizumab Versus S-1Cancer ManagementColorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentMedicineRadiation OncologyMolecular Oncology